ArticleEJNMMI physics2026
Image optimization for low-dose
Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundPositron emission tomography with magnetic resonance imaging (PET/MRI) provides noninvasive molecular characterization of breast cancer and has the potential to improve diagnostic accuracy, staging, treatment response assessment, and guide personalized care. Reducing the radiation dose from 2-deoxy-2-[
methodsThis pilot study was a secondary analysis of a single-institution prospective study of
resultsCompared to SLD, DN datasets scored better for artifacts, perceived signal-to-noise ratio, image sharpness/resolution, and overall image quality (p < 0.001). Compared to full-dose images, DN scored better than SLD for diagnostic image quality (p < 0.001) and lesion conspicuity (p = 0.002). For diagnostic image quality, DN was equivalent or slightly inferior to full-dose images in 89.9% (62/69) of reads. Readers preferred DN (76.8%; 53/69) to SLD (4.3%; 3/69), and both were preferred equally in 10.1% (7/69) of reads. Compared to SLD, quantitative image noise was less in DN images (p < 0.0001). Agreement was excellent between all datasets for tumor SUV
conclusionsAcceptable image quality may be achieved with low-dose
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.